28. October 2024

OPPENLÄNDER again honoured as JUVE TOP 50 commercial law firm

‘Competent. Reliable. Pragmatic. Successful.’ That’s how one client put it in a nutshell. We are very pleased about that!
Our clients praise both our professional expertise and the reliability of our lawyers. In addition to our broad experience in various areas of law, we impress with ‘practical and quick answers with an acceptable fee structure’.

Thank you for once again recognising us as a JUVE TOP 50 commercial law firm, and in particular to all our clients and colleagues for their recommendations!

The JUVE Handbook of Commercial Law Firms 2024/2025 particularly recognises our work in…

…antitrust law (Prof. Dr Albrecht Bach, Dr Andreas Hahn, Dr Ulrich Klumpp, Dr Matthias Ulshöfer, Dr Florian Schmidt-Volkmar and Dr Christoph Wolf)
…energy law regulation (Prof. Dr Markus Köhler, Dr Andreas Hahn, Dr Malte Weitner)
…Corporate Law (Dr Thomas Trölitzsch, Dr Rolf Leinekugel, Dr Felix Born)
…Healthcare (Dr Christina Koppe-Zagouras, Dr Katharina Köbler LL.M.)
…M&A (Dr Felix Born, Dr Rolf Leinekugel, Dr Thomas Trölitzsch, Dr Christian Gunßer)
…Public Commercial Law (Prof. Dr Christofer Lenz, Dr Corina Jürschik-Grau LL.M., Dr Torsten Gerhard)
…Public Procurement Law (Dr Matthias Ulshöfer)
…Trade Mark & Competition Law (Prof. Dr Markus Köhler, Dr Christina Koppe-Zagouras)
…transport sector (Dr Corina Jürschik-Grau LL.M., Prof. Dr Christofer Lenz, Prof. Dr Markus Köhler)

 

We would particularly like to congratulate our partners who were recognised as ‘leading advisors’:
Prof. Dr Albrecht Bach and Dr Andreas Hahn in antitrust law and Prof. Dr Christofer Lenz in public commercial law.

 

More news

04. June 2026

OPPENLÄNDER is strengthening its Intellectual Property and Healthcare practice with the addition of attorney Dr. Sonja Bühler, LL.M. (Edinburgh)

Dr. Sonja Bühler joined our Intellectual Property and Healthcare team in June 2026.

Read more
13. May 2026

OPPENLÄNDER wins lawsuit regarding claims for damages arising from pharmaceutical rebate contracts

Dr Matthias Ulshöfer and Dr Joachim Ott have successfully defended an international pharmaceutical company against unjustified claims for damages arising from pharmaceutical rebate contracts in a landmark case before the Munich Social Court. The actions brought by a major statutory health insurance fund were dismissed by way of a “judgment from the bench”.

Read more
01. April 2026

OPPENLÄNDER overturns minimum fares for ride-hailing services in Essen in a landmark case for BOLT

Dr. Henrike Schulte and Dr. Maximilian Gerhold of OPPENLÄNDER successfully secured a stay of a general administrative act issued by the City of Essen regarding minimum fares for ride-hailing services before the Administrative Court of Gelsenkirchen, acting on behalf of the European mobility platform BOLT and a Dortmund-based ride-hailing company.

Read more
12. February 2026

OPPENLÄNDER is once again among the best according to Legal500

In the recently published ranking of Legal 500 Germany 2026, we are once again a TOP LAW FIRM in the City Focus Stuttgart and are ranked as a TOP TIER LAW FIRM in two practice areas.

Read more